Pramlintide, as an adjunct to long-acting insulin, led to improved A1C and body weight in patients with type 2 diabetes

被引：0

|

作者：

Lush, Cameron

Strobel, Susan

Zhang, Bei

Frias, Juan

机构：

来源：

DIABETES | 2006年 / 55卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A124 / A124

页数：1

相关论文

共 50 条

[31] Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes - A 1-year randomized controlled trial
Hollander, PA
Levy, P
Fineman, M
Maggs, DG
Shen, LZ
Strobel, SA
Weyer, C
Kolterman, OG
[J]. DIABETES CARE, 2003, 26 (03) : 784 - 790
[32] Long-Acting Insulin Analogs Versus Insulin Pump Therapy for the Treatment of Type 1 and Type 2 Diabetes
Pickup, John C.
Renard, Eric
[J]. DIABETES CARE, 2008, 31 : S140 - S145
[33] Intermediate-acting versus long-acting insulin for type 1 diabetes mellitus
不详
[J]. JOURNAL OF DIABETES, 2009, 1 (03) : 138 - 138
[34] Type 2 diabetes: Which long-acting insulin should be preferred?
Nauck, Michael
[J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (34-35) : 1678 - 1678
[35] Increased insulin dose requirement of long-acting insulin analogues in obese patients with type 2 diabetes
Schmid, C.
Krayenbuhl, P.
Wiesli, P.
[J]. DIABETOLOGIA, 2009, 52 (12) : 2668 - 2669
[36] Cardiovascular safety of long-acting insulin analogs in type 2 diabetes patients: Is there a better basal insulin?
Chang, Chia-Hsuin
Chuang, Lee-Ming
[J]. JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (04): : 728 - 730
[37] Increased insulin dose requirement of long-acting insulin analogues in obese patients with type 2 diabetes
C. Schmid
P. Krayenbühl
P. Wiesli
[J]. Diabetologia, 2009, 52 : 2668 - 2669
[38] Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes treating to target with basal insulin
Riddle, Matthew
Zhang, Bei
Maier, Holly
Wilhelm, Ken
Kolterman, Orville
[J]. DIABETES, 2008, 57 : A156 - A156
[39] Pramlintide improved glycaemic control and reduced weight in patients with type 2 diabetes treating to target with basal insulin
Wilhelm, K.
Riddle, M.
Zhang, B.
Maier, H.
Kolterman, O.
[J]. DIABETOLOGIA, 2008, 51 : S409 - S409
[40] Pramlintide showed positive effects on body weight in type 1 and type 2 diabetes
Whitehouse, F
Ratner, R
Rosenstock, J
Schoenfeld, S
Kolterman, O
[J]. DIABETES, 1998, 47 : A9 - A9

← 1 2 3 4 5 →